Folate awareness and the prevalence of neural tube defects in South Australia, 1966-2007

Medical Journal of Australia

Volumn 189, Issue 10, 2008, Pages 566-569

  Chan, Annabelle C ^a,b   van Essen, Phillipa ^c   Scott, Heather ^c   Haan, Eric A ^b,c   Sage, Leonie ^a   Scott, Joan ^a   Gill, Tiffany K ^a   Nguyen, Anh Minh T ^a  

^a Government of South Australia   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADULT; ARTICLE; AUSTRALIA; AWARENESS; CEREAL; CHILDBIRTH; CONCEPTION; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HEALTH PROMOTION; HOUSEHOLD; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREGNANCY TERMINATION; PREGNANT WOMAN; PREVALENCE; RISK ASSESSMENT;

EID: 57149113940     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb02183.x     Document Type: Article

References (25)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991; 338: 131-137.
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835.
3. Australian Bureau of Statistics. National nutrition survey: nutrient intakes and physical measurements, Australia, 1995. Canberra: ABS, 1998. (ABS Cat. No. 4805.0.) http://www.abs.gov.au/ausstats/abs@nsf/ Lookup/95E87FE64B144FA3CA2568A9001393C0 (accessed Oct 2008).
4. Bower C, Blum L, O'Daly K, et al. Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995. Aust N Z J Public Health 1997; 21: 716-721. (erratum: Aust N Z J Public Health 1998; 22: 72.)
5. Chan A, Pickering J, Haan EA, et al. "Folate before pregnancy": the impact on women and health professionals of a population-based health promotion campaign in South Australia. Med J Aust 2001; 174: 631-636.
6. Chan A, Robertson EF, Haan EA, et al. Prevalence of neural tube defects in South Australia 1966-91; effectiveness and impact of prenatal diagnosis. BMJ 1993; 307: 703-706.
7. Taylor A, Dal Grande E, Starr G, Woollacott T. South Australian Health Goals and Targets Health Priority Areas Survey 2. Folate/spina bifida. Adelaide: South Australian Department of Human Services, 1999. http://www.library.health.sa.gov.au/Portals/0/ sa-health-goals-and-targets-health-priority-areas-survey- 2-folate-spina-bifida.pdf (accessed Oct 2008).
8. Dal Grande E, Gill T, Taylor A. Folate and spina bifida. Adelaide: South Australian Department of Human Services, 2002. http://www.health.sa.gov.au/pros/portals/0/folate-report-01.pdf (accessed Oct 2008).
9. South Australian Monitoring and Surveillance System (SAMSS). SAMSS Technical Paper Series No 1/04, August 2004. Survey methodology. Adelaide: South Australian Department of Health, 2004. http://www.health.sa.gov.au/pros/portals/0/samss-tech-paper1-method.pdf (accessed Oct 2008).
10. 2005 Annual Report of the South Australian Birth Defects Register. Children born from 1986 to 2005 with birth defects notified to the Register by 31st March 2006, and incorporating the Annual Report of Prenatal Diagnosis in South Australia, 2005. Adelaide: Children, Youth and Women's Health Service, Women's and Children's Hospital, 2008. http://www.wch.sa.gov.au/services/az/divisions/labs/geneticmed/documents/ 2005_sabdr_manual_report.pdf (accessed Oct 2008).
11. Henry A, Crowther C. Universal periconceptional folate supplementation: chasing a dream [letter]? Med J Aust 2000; 172: 407-408.
12. Conlin ML, MacLennan AH, Broadbent JL. Inadequate compliance with periconceptional folic acid supplementation in South Australia. Aust N Z J Obstet Gynaecol 2006; 46: 528-533.
13. Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public health challenge. Lancet 2006; 367: 1352-1361.
14. De Wals P, Tairou F, Van Allen MI, et al. Reduction of neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007; 357: 135-142.
15. Castilla EE, Orioli IM, Lopez-Carmelo JS, et al; for the ECLAMC. Latin American Collaborative Study of Congenital Malformations. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet A 2003; 123A: 123-128.
16. Chen LT, Rivera MA. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr Rev 2004; 62 (6 Pt 2): S40-S43.
17. Bentley TGK, Willett WC, Weinstein MC, et al. Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. Am J Public Health 2006; 96: 2040-2047.
18. Brent RL, Oakley GP. The Food and Drug Administration must require the addition of more folic acid in "enriched" flour and other grains. Pediatrics 2005; 116: 753-755.
19. Wald NJ, Law MR, Morris JK, et al. Quantifying the effect of folic acid. Lancet 2001; 358: 2069-2073.
20. Radar JI, Schneeman BO. Prevalence of neural tube defects, folate status, and folate fortification of enriched cereal-grain products in the United States. Pediatrics 2006; 117: 1394-1399.
21. Mills JL, Signore C. Neural tube defect rates before and after fortification with folic acid. Birth Defects Res A Clin Mol Teratol 2004; 70: 844-845.
22. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural tube defects with folic acid in China. N Engl J Med 1999; 341: 1485-1490.
23. Kirke PN, Mills JL, Molloy AM, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ 2004; 328: 1535-1536.
24. Food Standards Australia New Zealand. Amendment No.93 (FSC 35). 13 September 2007. http://www.foodstandards.gov.au/standardsdevelopment/ gazettenotices/amendment9313septemb3695.cfm (accessed Oct 2008).
25. Ray JG, Meier C, Vermeulen MJ, et al. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002; 360: 2047-2048.